Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Gero Miesenböck, the Waynflete Professor of Physiology and Director of the Centre for Neural Circuits and Behaviour, is one of three scientists awarded The Shaw Prize in Life Science and Medicine.

None

Department of Physiology, Anatomy & Genetics (DPAG) Professor Gero Miesenböck has received The Shaw Prize in Life Science and Medicine 2020 "for the development of optogenetics, a technology that has revolutionized neuroscience."

Optogenetics is a technique that uses light to control the activity of nerve cells. It provides a direct means of probing the organisation of neural circuits and of identifying the brain processes underlying perception, action, emotion, and thought. Professor Miesenböck was the first to demonstrate optogenetic control of neural activity and animal behaviour. His foundational studies led to an explosion in optogenetic applications and technical improvements.The field has ultimately transformed neuroscientific research and opened new possibilities for the treatment of brain disorders. 

Read more on the Department of Physiology, Anatomy & Genetics website

Read more about The Shaw Prize on The Shaw Foundation website

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.